Dr. Rajagopalan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
900 Centennial Blvd
Ste M
Voorhees, NJ 08043Phone+1 856-325-6750Fax+1 856-325-6777
Education & Training
- Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 1993 - 1997
- Lincoln Medical and Mental Health CenterResidency, Internal Medicine, 1991 - 1993
- Jawaharlal Institute of Postgraduate Medical Education and ResearchClass of 1987
Certifications & Licensure
- NJ State Medical License 2003 - 2025
- MD State Medical License 1997 - 2003
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- 4 citationsPembrolizumab Plus Chemotherapy for Metastatic NSCLC With Programmed Cell Death Ligand 1 Tumor Proportion Score Less Than 1%: Pooled Analysis of Outcomes After Five Ye...Shirish M Gadgeel, Delvys Rodríguez-Abreu, Balazs Halmos, Marina C Garassino, Takayasu Kurata
Journal of Thoracic Oncology. 2024-08-01 - 12 citationsStereotactic Body Radiotherapy Treatment for Recurrent, Previously Irradiated Head and Neck Cancer.Luke Stanisce, Yekaterina Koshkareva, Q. Xu, Ashish Patel, Christian Squillante
Technology in Cancer Research & Treatment. 2018-06-11 - Epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer: a decade of progress and hopeful future.Kumar Rajagopalan, Ramaswamy Govindan
Journal of Thoracic Disease. 2015-03-30
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: